{"groups":[{"description":"Patients with hyperprolactinemia were treated with long-term ROP therapy for 6 months in an open-label dose escalation study\n\nRopinirole: 0.25mg/day - 6.0mg/day oral non-ergoline dopamine agonist ropinirole","id":"FG000","title":"ROP Intervention"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Surgical resection"},{"reasons":[{"groupId":"FG000","numSubjects":"2"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Lost to Follow-up"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"15"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"11"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"4"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"1 Subject was determined to be ineligible after consenting."}